We then analyzed the ADAR2 protein level and localization in GBM tissues (39 samples) from a cohort of homogeneously treated patients (Supplementary Table S1) by performing a series of immunohistochemistry (IHC) experiments. The gene discussed is ADARB1; the disease is glioblastoma.